| [9] |
Torricelli M, Sabatini L, Florio P, et al. Levels of antibodies against protein C and protein S in pregnancy and in preeclampsia [J]. J Matern Fetal Neonatal Med, 2009，22(11): 993-999.
|
| [10] |
Ebina Y, Ieko M, Naito S, et al. Low levels of plasma protein S, protein C and coagulation factor XII during early pregnancy and adverse pregnancy outcome [J]. Thromb Haemost, 2015，114(1): 65-69.
|
| [11] |
Oliver JJ, Webb DJ, Newby DE. Stimulated tissue plasminogen activator release as a marker of endothelial function in humans [J]. Arterioscler Thromb Vasc Biol, 2005，25(12): 2470-2479.
|
| [12] |
Mone F, Mulcahy C, Mcparland P, et al. Trial of feasibility and acceptability of routine low-dose aspirin versus Early Screening Test indicated aspirin for pre-eclampsia prevention (TEST study): a multicentre randomised controlled trial [J]. BMJ Open, 2018，8: 1-9.
|
| [13] |
中华医学会妇产科学分会妊娠期高血压疾病学组．妊娠期高血压疾病诊治指南(2020) [J]. 中华妇产科杂志，2020，55(4): 227-238.
|
| [14] |
Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222 [J]. Obstet Gynecol, 2020，135(6): e237-e260.
|
| [15] |
Brown MA, Magee LA, Kenny LC, et al. Hypertensive Disorders of Pregnancy: ISSHP Classification, Diagnosis, and Management Recommendations for International Practice[J]. Hypertension, 2018，72(1): 24-43.
|
| [16] |
De Luca G, Secco GG, Iorio S, et al. Short-term effects of aspirin and clopidogrel on mean platelet volume among patients with acute coronary syndromes. A single-center prospective study [J]. Blood Coagul Fibrinolysis, 2012，23(8): 756-759.
|
| [17] |
Banala C, Moreno S, Cruz Y, et al. Impact of the ACOG guideline regarding low-dose aspirin for prevention of superimposed preeclampsia in women with chronic hypertension [J]. Am J Obstet Gynecol, 2020，223 (3): 419.e1-e16.
|
| [18] |
Mclaughlin K, Baczyk D, Potts A, et al. Low Molecular Weight Heparin Improves Endothelial Function in Pregnant Women at High Risk of Preeclampsia [J]. Hypertension, 2017，69(1): 180-188.
|
| [19] |
Rodger MA, Gris JC, De Vries JIP, et al. Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials [J]. Lancet, 2016，388(10060): 2629-2641.
|
| [20] |
D′souza R, Keating S, Walker M, et al. Unfractionated heparin and placental pathology in high-risk pregnancies: secondary analysis of a pilot randomized controlled trial [J]. Placenta, 2014，35(10): 816-823.
|
| [21] |
中华医学会妇产科学分会产科学组. 妊娠期及产褥期静脉血栓栓塞症预防和诊治专家共识 [J]. 中华妇产科杂志，2021，56(4): 236-243.
|
| [22] |
Backe SK, Lyons GR. High-dose tinzaparin in pregnancy and the need for urgent delivery [J]. Br J Anaesth, 2002，89(2): 331-334.
|
| [23] |
Roberge S, Demers S, Nicolaides KH, et al. Prevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: a meta-analysis [J]. Ultrasound Obstet Gynecol, 2016，47(5): 548-553.
|
| [24] |
Haddad B, Winer N, Chitrit Y, et al. Enoxaparin and Aspirin Compared With Aspirin Alone to Prevent Placenta-Mediated Pregnancy Complications: A Randomized Controlled Trial [J]. Obstet Gynecol, 2016，128 (5): 1053-1063.
|
| [25] |
Zhang Y, Shen F, Yang W, et al. Effects of low-molecular-weight heparin and aspirin in recurrent pre-eclampsia: A stratified cohort study [J]. Int J Gynaecol Obstet, 2021，154(2): 337-342.
|
| [1] |
Boij R, Svensson J, Nilsson-Ekdahl K, et al. Biomarkers of coagulation, inflammation, and angiogenesis are independently associated with preeclampsia [J]. Am J Reprod Immunol, 2012，68(3): 258-270.
|
| [2] |
Güngör ZB, Ekmekçi H, Tüten A, et al. Is there any relationship between adipocytokines and angiogenesis factors to address endothelial dysfunction and platelet aggregation in untreated patients with preeclampsia? [J]. Arch Gynecol Obstet, 2017，296(3): 495-502.
|
| [3] |
Erez O, Mastrolia SA, Thachil J. Disseminated intravascular coagulation in pregnancy: insights in pathophysiology, diagnosis and management [J]. Am J Obstet Gynecol, 2015，213(4): 452-463.
|
| [4] |
Peraçoli MT, Menegon FT, Borges VT, et al. Platelet aggregation and TGF-beta(1) plasma levels in pregnant women with preeclampsia [J]. J Reprod Immunol, 2008，79(1): 79-84.
|
| [5] |
Duan Z, Li C, Leung WT, et al. Alterations of Several Serum Parameters Are Associated with Preeclampsia and May Be Potential Markers for the Assessment of PE Severity [J]. Dis Markers, 2020，2020: 1-7.
|
| [6] |
Han L, Liu X, Li H, et al. Blood Coagulation Parameters and Platelet Indices: Changes in Normal and Preeclamptic Pregnancies and Predictive Values for Preeclampsia [J]. PLoS ONE, 2014，9(12): 1-14.
|
| [7] |
Erez O, Novack L, Beer-Weisel R, et al. DIC score in pregnant women--a population based modification of the International Society on Thrombosis and Hemostasis score [J]. PLoS One, 2014，9(4): 1-10.
|
| [8] |
赵茵. 产科弥散性血管内凝血 [J]. 临床血液学杂志，2018，31(1): 10-13.
|